110.37
2.03 (1.87%)
| Penutupan Terdahulu | 108.34 |
| Buka | 106.70 |
| Jumlah Dagangan | 54,858 |
| Purata Dagangan (3B) | 226,982 |
| Modal Pasaran | 2,689,275,392 |
| Harga / Pendapatan (P/E Ke hadapan) | 21.98 |
| Harga / Jualan (P/S) | 1.65 |
| Harga / Buku (P/B) | 1.90 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 5 Aug 2024 - 9 Aug 2024 |
| Margin Keuntungan | -4.74% |
| Margin Operasi (TTM) | 3.58% |
| EPS Cair (TTM) | -4.56 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 6.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 81.03% |
| Nisbah Semasa (MRQ) | 2.29 |
| Aliran Tunai Operasi (OCF TTM) | 255.11 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 280.08 M |
| Pulangan Atas Aset (ROA TTM) | 0.66% |
| Pulangan Atas Ekuiti (ROE TTM) | -5.35% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Bercampur | Bercampur |
| Medical Instruments & Supplies (Global) | Bercampur | Bercampur | |
| Stok | ICU Medical, Inc. | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 5.0 |
| Aktiviti Orang Dalam | -1.5 |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | 0.20 |
|
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 7.84% |
| % Dimiliki oleh Institusi | 101.05% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 209.00 (Keybanc, 89.36%) | Beli |
| Median | 204.50 (85.29%) | |
| Rendah | 200.00 (Jefferies, 81.21%) | Beli |
| Purata | 204.50 (85.29%) | |
| Jumlah | 2 Beli | |
| Harga Purata @ Panggilan | 170.50 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Jefferies | 11 Dec 2024 | 200.00 (81.21%) | Beli | 166.19 |
| 14 Oct 2024 | 183.00 (65.81%) | Pegang | 180.30 | |
| Keybanc | 13 Nov 2024 | 209.00 (89.36%) | Beli | 174.81 |
| 15 Oct 2024 | 198.00 (79.40%) | Beli | 179.50 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 12 Nov 2024 | Pengumuman | ICU Medical Announces Third Quarter 2024 Results and Updates Its Fiscal Year 2024 Guidance |
| 12 Nov 2024 | Pengumuman | ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc., a Subsidiary of Otsuka Holdings Co. Ltd., Announce Creation of a Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America |
| 06 Nov 2024 | Pengumuman | ICU Medical to Participate at the UBS Global Healthcare Conference |
| 28 Oct 2024 | Pengumuman | ICU Medical Announces Time of Third Quarter 2024 Earnings Conference Call |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2024 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |